Neuroprotection in glaucoma - Is there a future role?

Experimental Eye Research

Volumn 91, Issue 5, 2010, Pages 554-566

  Baltmr, Abeir ^a   Duggan, James ^a   Nizari, Shereen ^a   Salt, Thomas E ^a   Cordeiro, M Francesca ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b WESTERN EYE HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Glaucoma; Neuroprotection; Retinal ganglion cells

Indexed keywords

AMINOGUANIDINE; ARACHIDONIC ACID; BIRC 4; CAROTENOID; CONGO RED; CREATINE; CURCUMIN; DILTIAZEM; DIZOCILPINE; EGLUMETAD; ELIPRODIL; ERYTHROPOIETIN; FLUNARIZINE; GALANTAMINE; GINKGO BILOBA EXTRACT; GLATIRAMER; GLC 756; IFENPRODIL; MELATONIN; MEMANTINE; NEUROPROTECTIVE AGENT; NICOTINAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHENYTOIN; PITAVASTATIN; PROPOLIS; RILUZOLE; SYNAPTOPHYSIN; TACROLIMUS; THIOCTIC ACID; TOCOPHEROL; TOPIRAMATE; UK 14; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; DRUG ACTIVITY; DRUG MECHANISM; GINKGO BILOBA; GLAUCOMA; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FOLDING; RETINA GANGLION CELL; REVIEW; TARGET CELL; ANIMAL; CELL SURVIVAL; DRUG EFFECT; HUMAN; OPTIC NERVE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL SURVIVAL; GLAUCOMA; HUMANS; NEUROPROTECTIVE AGENTS; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS;

EID: 78049508657     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.08.009     Document Type: Review

References (271)

1. Abe Y., Hashimoto S., Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacological Research 1999, 39:41-47.
2. Almasieh M., Zhou Y., Kelly M.E., Casanova C., Di Polo A. Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors. Cell Death and Disease 2010, 1.
3. Anderson D.R., Hendrickson A. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Investigative Ophthalmology 1974, 13:771-783.
4. Andrabi S.A., Sayeed I., Siemen D., Wolf G., Horn T.F. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB Journal 2004, 18:869-871.
5. Aoun P., Simpkins J.W., Agarwal N. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Investigative Ophthalmology and Visual Science 2003, 44:2999-3004.
6. Attems J., Jellinger K.A. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clinical Neuropathology 2006, 25:265-271.
7. Augustin S., Rimbach G., Augustin K., Schliebs R., Wolffram S., Cermak R. Effect of a short- and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer's disease. Archives of Biochemistry and Biophysics 2009, 481:177-182.
8. Aydemir O., Naziroglu M., Celebi S., Yilmaz T., Kukner A.S. Antioxidant effects of alpha-, gamma- and succinate-tocopherols in guinea pig retina during ischemia-reperfusion injury. Pathophysiology 2004, 11:167-171.
9. Bakalash S., Kessler A., Mizrahi T., Nussenblatt R., Schwartz M. Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma. Investigative Ophthalmology and Visual Science 2003, 44:3374-3381.
10. Barde Y.A., Edgar D., Thoenen H. Purification of a new neurotrophic factor from mammalian brain. The EMBO Journal 1982, 1:549-553.
11. Bastianetto S., Ramassamy C., Dore S., Christen Y., Poirier J., Quirion R. The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. The European Journal of Neuroscience 2000, 12:1882-1890.
12. Bastianetto S., Zheng W.H., Quirion R. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. Journal of Neurochemistry 2000, 74:2268-2277.
13. Bayer A.U., Keller O.N., Ferrari F., Maag K.P. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. American Journal of Ophthalmology 2002, 133:135-137.
14. Beal M.F. Bioenergetic approaches for neuroprotection in Parkinson's disease. Annals of Neurology 2003, 53(Suppl. 3):S39-47. discussion S47-S38.
15. Behrens M.M., Strasser U., Heidinger V., Lobner D., Yu S.P., McDonald J.W., Won M., Choi D.W. Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity. Neuropharmacology 1999, 38:1621-1630.
16. Ben Simon G.J., Bakalash S., Aloni E., Rosner M. A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy. American Journal of Ophthalmology 2006, 141:1105-1111.
17. Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. The New England Journal of Medicine 1994, 330:585-591.
18. Berkelaar M., Clarke D.B., Wang Y.C., Bray G.M., Aguayo A.J. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. Journal of Neuroscience 1994, 14:4368-4374.
19. Berkemeier L.R., Winslow J.W., Kaplan D.R., Nikolics K., Goeddel D.V., Rosenthal A. Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 1991, 7:857-866.
20. Borras T., Brandt C.R., Nickells R., Ritch R. Gene therapy for glaucoma: treating a multifaceted, chronic disease. Investigative Ophthalmology and Visual Science 2002, 43:2513-2518.
21. Brooks D.E., Garcia G.A., Dreyer E.B., Zurakowski D., Franco-Bourland R.E. Vitreous body glutamate concentration in dogs with glaucoma. American Journal of Veterinary Research 1997, 58:864-867.
22. Calzada J.I., Jones B.E., Netland P.A., Johnson D.A. Glutamate-induced excitotoxicity in retina: neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers. Neurochemical Research 2002, 27:79-88.
23. Casson R.J. Possible role of excitotoxicity in the pathogenesis of glaucoma. Clinical & Experimental Ophthalmology 2006, 34:54-63.
24. Cazevieille C., Osborne N.N. Retinal neurones containing kainate receptors are influenced by exogenous kainate and ischaemia while neurones lacking these receptors are not - melatonin counteracts the effects of ischaemia and kainate. Brain Research 1997, 755:91-100.
25. Cazevieille C., Safa R., Osborne N.N. Melatonin protects primary cultures of rat cortical neurones from NMDA excitotoxicity and hypoxia/reoxygenation. Brain Research 1997, 768:120-124.
26. Chaudhary P., Ahmed F., Sharma S.C. MK801-a neuroprotectant in rat hypertensive eyes. Brain Research 1998, 792:154-158.
27. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science (New York, NY) 2002, 296:1634-1635.
28. Cheng L., Sapieha P., Kittlerova P., Hauswirth W.W., Di Polo A. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. Journal of Neuroscience 2002, 22:3977-3986.
29. Cheung W., Guo L., Cordeiro M.F. Neuroprotection in glaucoma: drug-based approaches. Optometry and Vision Science 2008, 85:406-416.
30. Chidlow G., Schmidt K.G., Wood J.P., Melena J., Osborne N.N. Alpha-lipoic acid protects the retina against ischemia-reperfusion. Neuropharmacology 2002, 43:1015-1025.
31. Chidlow G., Wood J.P., Casson R.J. Pharmacological neuroprotection for glaucoma. Drugs 2007, 67:725-759.
32. Choi D.W. Excitotoxic cell death. Journal of Neurobiology 1992, 23:1261-1276.
33. Chung H.S., Harris A., Kristinsson J.K., Ciulla T.A., Kagemann C., Ritch R. Ginkgo biloba extract increases ocular blood flow velocity. Journal of Ocular Pharmacology and Therapeutics 1999, 15:233-240.
34. Colafrancesco V., Parisi V., Sposato V., Rossi S., Russo M.A., Coassin M., Lambiase A., Aloe L. Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma. Journal of Glaucoma 2010.
35. Cordeiro M.F., Guo L., Luong V., Harding G., Wang W., Jones H.E., Moss S.E., Sillito A.M., Fitzke F.W. Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:13352-13356.
36. Cordeiro M.F., Nickells R., Drexler W., Borras T., Ritch R. High-resolution ocular imaging: combining advanced optics and microtechnology. Ophthalmic Surgery, Lasers and Imaging 2009, 40:480-488.
37. Cui Q., Harvey A.R. At least two mechanisms are involved in the death of retinal ganglion cells following target ablation in neonatal rats. Journal of Neuroscience 1995, 15:8143-8155.
38. Cunha R.A., Ribeiro J.A., Malva J.O. Presynaptic kainate receptors modulating glutamatergic transmission in the rat hippocampus are inhibited by arachidonic acid. Neurochemistry International 2004, 44:371-379.
39. D'Astous M., Morissette M., Di Paolo T. Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist. Neuropharmacology 2004, 47:1180-1188.
40. Diamond B.J., Shiflett S.C., Feiwel N., Matheis R.J., Noskin O., Richards J.A., Schoenberger N.E. Ginkgo biloba extract: mechanisms and clinical indications. Archives of Physical Medicine and Rehabilitation 2000, 81:668-678.
41. Digicaylioglu M., Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001, 412:641-647.
42. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacology & Therapeutics 1999, 81:163-221.
43. Donello J.E., Padillo E.U., Webster M.L., Wheeler L.A., Gil D.W. alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. Journal of Pharmacology and Experimental Therapeutics 2001, 296:216-223.
44. Dong C.J., Guo Y., Agey P., Wheeler L., Hare W.A. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity. Investigative Ophthalmology and Visual Science 2008, 49:4515-4522.
45. Dreyer E.B., Zurakowski D., Schumer R.A., Podos S.M., Lipton S.A. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Archives of Ophthalmology 1996, 114:299-305.
46. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S., Wise P.M. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:1952-1957.
47. Dubocovich M.L., Masana M.I., Iacob S., Sauri D.M. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn-Schmiedeberg's Archives of Pharmacology 1997, 355:365-375.
48. Duhaime A.C., Gennarelli L.M., Boardman C. Neuroprotection by dextromethorphan in acute experimental subdural hematoma in the rat. Journal of Neurotrauma 1996, 13:79-84.
49. Dykens J.A., Carroll A.K., Wiley S., Covey D.F., Cai Z.Y., Zhao L., Wen R. Photoreceptor preservation in the S334ter model of retinitis pigmentosa by a novel estradiol analog. Biochemical Pharmacology 2004, 68:1971-1984.
50. el-Asrar A.M., Morse P.H., Maimone D., Torczynski E., Reder A.T. MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. Investigative Ophthalmology and Visual Science 1992, 33:3463-3468.
51. El-Remessy A.B., Khalil I.E., Matragoon S., Abou-Mohamed G., Tsai N.J., Roon P., Caldwell R.B., Caldwell R.W., Green K., Liou G.I. Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-d-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. The American Journal of Pathology 2003, 163:1997-2008.
52. Eschweiler G.W., Bahr M. Flunarizine enhances rat retinal ganglion cell survival after axotomy. Journal of the Neurological Sciences 1993, 116:34-40.
53. Ettaiche M., Fillacier K., Widmann C., Heurteaux C., Lazdunski M. Riluzole improves functional recovery after ischemia in the rat retina. Investigative Ophthalmology and Visual Science 1999, 40:729-736.
54. Evans Pharmacognosy 2002, W.B. Saunders, Philadelphia. 17th ed.
55. Fingert J.H., Heon E., Liebmann J.M., Yamamoto T., Craig J.E., Rait J., Kawase K., Hoh S.T., Buys Y.M., Dickinson J., et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Human Molecular Genetics 1999, 8:899-905.
56. Finkel T. Oxygen radicals and signaling. Current Opinion in Cell Biology 1998, 10:248-253.
57. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
58. Fix A.S., Horn J.W., Wightman K.A., Johnson C.A., Long G.G., Storts R.W., Farber N., Wozniak D.F., Olney J.W. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-d-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Experimental Neurology 1993, 123:204-215.
59. Flammer J., Haefliger I.O., Orgul S., Resink T. Vascular dysregulation: a principal risk factor for glaucomatous damage?. Journal of Glaucoma 1999, 8:212-219.
60. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. Journal of Neuroscience 2002, 22:RC216.
61. Foster A.C., Gill R., Woodruff G.N. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. Journal of Neuroscience 1988, 8:4745-4754.
62. Gandolfi S.A., Sangermani C., Cimino L., Ungaro N., Tardini M., Viswanathan A., Hitchings R. Is there a non IOP-related effect of brimonidine on visual field progression in human glaucoma?. Investigative Ophthalmology and Visual Science 2004, 45:2298.
63. Garcia-Segura L.M., Cardona-Gomez P., Naftolin F., Chowen J.A. Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport 1998, 9:593-597.
64. Gibbs J.W., Sombati S., DeLorenzo R.J., Coulter D.A. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 2000, 41(Suppl. 1):S10-16.
65. Goldberg M.P., Pham P.C., Choi D.W. Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture. Neuroscience Letters 1987, 80:11-15.
66. Goldblum D., Kipfer-Kauer A., Sarra G.M., Wolf S., Frueh B.E. Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas. Investigative Ophthalmology and Visual Science 2007, 48:5085-5090.
67. Gross R.L., Hensley S.H., Gao F., Wu S.M. Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of beta-blockers. Survey of Ophthalmology 1999, 43(Suppl. 1):S162-170.
68. Guo L., Moss S.E., Alexander R.A., Ali R.R., Fitzke F.W., Cordeiro M.F. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Investigative Ophthalmology and Visual Science 2005, 46:175-182.
69. Guo L., Salt T.E., Luong V., Wood N., Cheung W., Maass A., Ferrari G., Russo-Marie F., Sillito A.M., Cheetham M.E., et al. Targeting amyloid-beta in glaucoma treatment. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:13444-13449.
70. Guo L., Salt T.E., Maass A., Luong V., Moss S.E., Fitzke F.W., Cordeiro M.F. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Investigative Ophthalmology and Visual Science 2006, 47:626-633.
71. Gupta N., Ang L.C., Noel de Tilly L., Bidaisee L., Yucel Y.H. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. British Journal of Ophthalmology 2006, 90:674-678.
72. Hagen T.M., Ingersoll R.T., Lykkesfeldt J., Liu J., Wehr C.M., Vinarsky V., Bartholomew J.C., Ames A.B. (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB Journal 1999, 13:411-418.
73. Hains B.C., Waxman S.G. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma. Investigative Ophthalmology and Visual Science 2005, 46:4164-4169.
74. Harvey A.R., Hu Y., Leaver S.G., Mellough C.B., Park K., Verhaagen J., Plant G.W., Cui Q. Gene therapy and transplantation in CNS repair: the visual system. Progress in Retinal and Eye Research 2006, 25:449-489.
75. Hayreh S.S., March W., Anderson D.R. Pathogenesis of block of rapid orthograde axonal transport by elevated intraocular pressure. Experimental Eye Research 1979, 28:515-523.
76. Hernandez M., Urcola J.H., Vecino E. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments. Experimental Eye Research 2008, 86:798-806.
77. Hirooka K., Tokuda M., Miyamoto O., Itano T., Baba T., Shiraga F. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Current Eye Research 2004, 28:153-157.
78. Hirsch T., Marchetti P., Susin S.A., Dallaporta B., Zamzami N., Marzo I., Geuskens M., Kroemer G. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997, 15:1573-1581.
79. Hoffman G.E., Merchenthaler I., Zup S.L. Neuroprotection by ovarian hormones in animal models of neurological disease. Endocrine 2006, 29:217-231.
80. Hohn A., Leibrock J., Bailey K., Barde Y.A. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 1990, 344:339-341.
81. Honda K., Sawada H., Kihara T., Urushitani M., Nakamizo T., Akaike A., Shimohama S. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. Journal of Neuroscience Research 2000, 60:321-327.
82. Hong S., Kim C.Y., Lee J.E., Seong G.J. Agmatine protects cultured retinal ganglion cells from tumor necrosis factor-alpha-induced apoptosis. Life Science 2009, 84:28-32.
83. Hong S., Park K., Kim C.Y., Seong G.J. Agmatine inhibits hypoxia-induced TNF-alpha release from cultured retinal ganglion cells. Biocell 2008, 32:201-205.
84. Howell G.R., Libby R.T., Jakobs T.C., Smith R.S., Phalan F.C., Barter J.W., Barbay J.M., Marchant J.K., Mahesh N., Porciatti V., et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. Journal of Cell Biology 2007, 179:1523-1537.
85. Huang W., Fileta J.B., Dobberfuhl A., Filippopolous T., Guo Y., Kwon G., Grosskreutz C.L. Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:12242-12247.
86. Hyndman A.G. The effects of glutamate and kainate on cell proliferation in retinal cultures. Investigative Ophthalmology and Visual Science 1984, 25:558-563.
87. Inokuchi Y., Shimazawa M., Nakajima Y., Suemori S., Mishima S., Hara H. Brazilian green propolis protects against retinal damage in vitro and in vivo. Evidence-based Complementary and Alternative Medicine 2006, 3:71-77.
88. Ishii Y., Kwong J.M., Caprioli J. Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model. Investigative Ophthalmology and Visual Science 2003, 44:1982-1992.
89. Jelsma T.N., Friedman H.H., Berkelaar M., Bray G.M., Aguayo A.J. Different forms of the neurotrophin receptor trkB mRNA predominate in rat retina and optic nerve. Journal of Neurobiology 1993, 24:1207-1214.
90. Ji J.Z., Elyaman W., Yip H.K., Lee V.W., Yick L.W., Hugon J., So K.F. CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. European Journal of Neuroscience 2004, 19:265-272.
91. Jiang C., Moore M.J., Zhang X., Klassen H., Langer R., Young M. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma. Molecular Vision 2007, 13:1783-1792.
92. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 1996, 85:1113-1124.
93. Johnson J.E., Barde Y.A., Schwab M., Thoenen H. Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. Journal of Neuroscience 1986, 6:3031-3038.
94. Johnson J.W., Kotermanski S.E. Mechanism of action of memantine. Current Opinion in Pharmacology 2006, 6:61-67.
95. Johnson L.V., Leitner W.P., Rivest A.J., Staples M.K., Radeke M.J., Anderson D.H. The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:11830-11835.
96. Johnson T.V., Tomarev S.I. Rodent models of glaucoma. Brain Research Bulletin 2010, 81:349-358.
97. Jou M.J., Peng T.I., Reiter R.J., Jou S.B., Wu H.Y., Wen S.T. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. Journal of Pineal Research 2004, 37:55-70.
98. Ju W.K., Kim K.Y., Angert M., Duong-Polk K.X., Lindsey J.D., Ellisman M.H., Weinreb R.N. Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Investigative Ophthalmology and Visual Science 2009, 50:707-716.
99. Junk A.K., Mammis A., Savitz S.I., Singh M., Roth S., Malhotra S., Rosenbaum P.S., Cerami A., Brines M., Rosenbaum D.M. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:10659-10664.
100. Juravleva E., Barbakadze T., Mikeladze D., Kekelidze T. Creatine enhances survival of glutamate-treated neuronal/glial cells, modulates Ras/NF-kappaB signaling, and increases the generation of reactive oxygen species. Journal of Neuroscience Research 2005, 79:224-230.
101. Kanowski S., Herrmann W.M., Stephan K., Wierich W., Horr R. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 1996, 29:47-56.
102. Kanowski S., Hoerr R. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry 2003, 36:297-303.
103. Kapin M.A., Doshi R., Scatton B., DeSantis L.M., Chandler M.L. Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia. Investigative Ophthalmology and Visual Science 1999, 40:1177-1182.
104. Kaplan D.R., Hempstead B.L., Martin-Zanca D., Chao M.V., Parada L.F. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 1991, 252:554-558.
105. Katsuki H., Yamamoto R., Nakata D., Kume T., Akaike A. Neuronal nitric oxide synthase is crucial for ganglion cell death in rat retinal explant cultures. Journal of Pharmacological Science 2004, 94:77-80.
106. Kaur C., Foulds W.S., Ling E.A. Hypoxia-ischemia and retinal ganglion cell damage. Clinical Ophthalmology 2008, 2:879-889.
107. Kawasaki A., Han M.H., Wei J.Y., Hirata K., Otori Y., Barnstable C.J. Protective effect of arachidonic acid on glutamate neurotoxicity in rat retinal ganglion cells. Investigative Ophthalmology and Visual Science 2002, 43:1835-1842.
108. Kawasaki A., Otori Y., Barnstable C.J. Muller cell protection of rat retinal ganglion cells from glutamate and nitric oxide neurotoxicity. Investigative Ophthalmology and Visual Science 2000, 41:3444-3450.
109. Kerrigan L.A., Zack D.J., Quigley H.A., Smith S.D., Pease M.E. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Archives of Ophthalmology 1997, 115:1031-1035.
110. Khoury R., Cross J.M., Girkin C.A., Owsley C., McGwin G. The association between self-reported glaucoma and ginkgo biloba use. Journal of Glaucoma 2009, 18:543-545.
111. Kikuchi M., Tenneti L., Lipton S.A. Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. Journal of Neuroscience 2000, 20:5037-5044.
112. Kilic E., Kilic U., Yulug B., Hermann D.M., Reiter R.J. Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator. Journal of Pineal Research 2004, 36:171-176.
113. Kilic U., Kilic E., Reiter R.J., Bassetti C.L., Hermann D.M. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. Journal of Pineal Research 2005, 38:67-71.
114. Kilic U., Kilic E., Soliz J., Bassetti C.I., Gassmann M., Hermann D.M. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB Journal 2005, 19:249-251.
115. Kim T.W., Kim D.M., Park K.H., Kim H. Neuroprotective effect of memantine in a rabbit model of optic nerve ischemia. Korean Journal of Ophthalmology 2002, 16:1-7.
116. Kipnis J., Yoles E., Porat Z., Cohen A., Mor F., Sela M., Cohen I.R., Schwartz M. T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:7446-7451.
117. Klivenyi P., Ferrante R.J., Matthews R.T., Bogdanov M.B., Klein A.M., Andreassen O.A., Mueller G., Wermer M., Kaddurah-Daouk R., Beal M.F. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Medicine 1999, 5:347-350.
118. Knels L., Worm M., Wendel M., Roehlecke C., Kniep E., Funk R.H. Effects of advanced glycation end products-inductor glyoxal and hydrogen peroxide as oxidative stress factors on rat retinal organ cultures and neuroprotection by UK-14,304. Journal of Neurochemistry 2008, 106:1876-1887.
119. Ko M.L., Peng P.H., Ma M.C., Ritch R., Chen C.F. Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radical Biology and Medicine 2005, 39:365-373.
120. Kobayashi K., Kobayashi H., Ueda M., Honda Y. Estrogen receptor expression in bovine and rat retinas. Investigative Ophthalmology and Visual Science 1998, 39:2105-2110.
121. Kristian T., Siesjo B.K. Calcium in ischemic cell death. Stroke 1998, 29:705-718.
122. Krupin T., Liebmann J.M., Greenfield D.S., Rosenberg L.F., Ritch R., Yang J.W. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients. Ophthalmology 2005, 112:376-385.
123. Kumar D.M., Perez E., Cai Z.Y., Aoun P., Brun-Zinkernagel A.M., Covey D.F., Simpkins J.W., Agarwal N. Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity. Free Radical Biology and Medicine 2005, 38:1152-1163.
124. Kwon Y.H., Fingert J.H., Kuehn M.H., Alward W.L. Primary open-angle glaucoma. New England Journal of Medicine 2009, 360:1113-1124.
125. Lacomblez L., Bensimon G., Leigh P.N., Guillet P., Powe L., Durrleman S., Delumeau J.C., Meininger V. A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology 1996, 47:S242-250.
126. Laengle U.W., Markstein R., Pralet D., Seewald W., Roman D. Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells. Experimental Eye Research 2006, 83:1335-1339.
127. Laengle U.W., Trendelenburg A.U., Markstein R., Nogues V., Provencher-Bollinger A., Roman D. GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanism. Experimental Eye Research 2006, 83:1246-1251.
128. Lagreze W.A., Knorle R., Bach M., Feuerstein T.J. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Investigative Ophthalmology and Visual Science 1998, 39:1063-1066.
129. Lai R.K., Chun T., Hasson D., Lee S., Mehrbod F., Wheeler L. Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat. Vision in Neuroscience 2002, 19:175-185.
130. Lambert W.S., Clark A.F., Wordinger R.J. Effect of exogenous neurotrophins on Trk receptor phosphorylation, cell proliferation, and neurotrophin secretion by cells isolated from the human lamina cribrosa. Molecular Vision 2004, 10:289-296.
131. Lambiase A., Aloe L., Centofanti M., Parisi V., Mantelli F., Colafrancesco V., Manni G.L., Bucci M.G., Bonini S., Levi-Montalcini R. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma. Proceedings of the National Academy of Sciences of the United States of America 2009.
132. Lebrun-Julien F., Duplan L., Pernet V., Osswald I., Sapieha P., Bourgeois P., Dickson K., Bowie D., Barker P.A., Di Polo A. Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism. Journal of Neuroscience 2009, 29:5536-5545.
133. Lee S.H., Chun W., Kong P.J., Han J.A., Cho B.P., Kwon O.Y., Lee H.J., Kim S.S. Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus. Journal of Pineal Research 2006, 40:79-85.
134. Leinders-Zufall T., Rand M.N., Waxman S.G., Kocsis J.D. Differential role of two Ca(2+)-permeable non-NMDA glutamate channels in rat retinal ganglion cells: kainate-induced cytoplasmic and nuclear Ca2+ signals. Journal of Neurophysiology 1994, 72:2503-2516.
135. Levin L.A., Peeples P. History of neuroprotection and rationale as a therapy for glaucoma. American Journal of Management Care 2008, 14:S11-14.
136. Li S.Y., Fu Z.J., Ma H., Jang W.C., So K.F., Wong D., Lo A.C. Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion. Investigative Ophthalmology and Visual Science 2009, 50:836-843.
137. Li X., Qian S.H., Sun X.H. Zhonghua Yi Xue Za Zhi 2008, 88:2152-2154.
138. Libby R.T., Gould D.B., Anderson M.G., John S.W. Complex genetics of glaucoma susceptibility. Annual Review of Genomics and Human Genetics 2005, 6:15-44.
139. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Journal of Neuroscience 2001, 21:8370-8377.
140. Lipton S.A. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends in Neuroscience 1993, 16:527-532.
141. Lipton S.A. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nature Reviews Drug Discovery 2006, 5:160-170.
142. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., Cotman C.W., Ames B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-l-carnitine and/or R-alpha-lipoic acid. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:2356-2361.
143. Liu X., Rasmussen C.A., Gabelt B.T., Brandt C.R., Kaufman P.L. Gene therapy targeting glaucoma: where are we?. Survey of Ophthalmology 2009, 54:472-486.
144. Lorenzo A., Yankner B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:12243-12247.
145. Luo X., Heidinger V., Picaud S., Lambrou G., Dreyfus H., Sahel J., Hicks D. Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro. Investigative Ophthalmology and Visual Science 2001, 42:1096-1106.
146. Mabuchi F., Tang S., Kashiwagi K., Yamagata Z., Iijima H., Tsukahara S. The OPA1 gene polymorphism is associated with normal tension and high tension glaucoma. American Journal of Ophthalmology 2007, 143:125-130.
147. Mandal M.N., Patlolla J.M., Zheng L., Agbaga M.P., Tran J.T., Wicker L., Kasus-Jacobi A., Elliott M.H., Rao C.V., Anderson R.E. Curcumin protects retinal cells from light-and oxidant stress-induced cell death. Free Radical Biology and Medicine 2009, 46:672-679.
148. Mansour-Robaey S., Clarke D.B., Wang Y.C., Bray G.M., Aguayo A.J. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:1632-1636.
149. Marchetti P., Castedo M., Susin S.A., Zamzami N., Hirsch T., Macho A., Haeffner A., Hirsch F., Geuskens M., Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. Journal of Experimental Medicine 1996, 184:1155-1160.
150. Matteucci A., Frank C., Domenici M.R., Balduzzi M., Paradisi S., Carnovale-Scalzo G., Scorcia G., Malchiodi-Albedi F. Curcumin treatment protects rat retinal neurons against excitotoxicity: effect on N-methyl-d: -aspartate-induced intracellular Ca(2+) increase. Experimental Brain Research 2005, 167:641-648.
151. Matthews R.T., Ferrante R.J., Klivenyi P., Yang L., Klein A.M., Mueller G., Kaddurah-Daouk R., Beal M.F. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Experimental Neurology 1999, 157:142-149.
152. Matthews R.T., Yang L., Jenkins B.G., Ferrante R.J., Rosen B.R., Kaddurah-Daouk R., Beal M.F. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. Journal of Neuroscience 1998, 18:156-163.
153. McIlnay T.R., Gionfriddo J.R., Dubielzig R.R., Powell C.C., Madl J.E. Evaluation of glutamate loss from damaged retinal cells of dogs with primary glaucoma. American Journal of Veterinary Research 2004, 65:776-786.
154. McKinnon S.J., Lehman D.M., Kerrigan-Baumrind L.A., Merges C.A., Pease M.E., Kerrigan D.F., Ransom N.L., Tahzib N.G., Reitsamer H.A., Levkovitch-Verbin H., et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Investigative Ophthalmology and Visual Science 2002, 43:1077-1087.
155. McKinnon S.J., Lehman D.M., Tahzib N.G., Ransom N.L., Reitsamer H.A., Liston P., LaCasse E., Li Q., Korneluk R.G., Hauswirth W.W. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Molecular Therapy 2002, 5:780-787.
156. Mittag T.W., Danias J., Pohorenec G., Yuan H.M., Burakgazi E., Chalmers-Redman R., Podos S.M., Tatton W.G. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Investigative Ophthalmology and Visual Science 2000, 41:3451-3459.
157. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nature Medicine 1999, 5:49-55.
158. Moalem G., Yoles E., Leibowitz-Amit R., Muller-Gilor S., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells retard the loss of function in injured rat optic nerves. Journal of Neuroimmunology 2000, 106:189-197.
159. Moreno M.C., Sande P., Marcos H.A., de Zavalia N., Keller Sarmiento M.I., Rosenstein R.E. Effect of glaucoma on the retinal glutamate/glutamine cycle activity. FASEB Journal 2005, 19:1161-1162.
160. Mosinger J.L., Price M.T., Bai H.Y., Xiao H., Wozniak D.F., Olney J.W. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Experimental Neurology 1991, 113:10-17.
161. Murphy M.P. Nitric oxide and cell death. Biochimica et Biophysica Acta 1999, 1411:401-414.
162. Nakajima Y., Inokuchi Y., Nishi M., Shimazawa M., Otsubo K., Hara H. Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo. Brain Research 2008, 1226:226-233.
163. Nakajima Y., Shimazawa M., Mishima S., Hara H. Neuroprotective effects of Brazilian green propolis and its main constituents against oxygen-glucose deprivation stress, with a gene-expression analysis. Phytotherapy Research 2009, 23:1431-1438.
164. Nakajima Y., Shimazawa M., Otsubo K., Ishibashi T., Hara H. Zeaxanthin, a retinal carotenoid, protects retinal cells against oxidative stress. Current Eye Research 2009, 34:311-318.
165. Nakazawa T., Takahashi H., Nishijima K., Shimura M., Fuse N., Tamai M., Hafezi-Moghadam A., Nishida K. Pitavastatin prevents NMDA-induced retinal ganglion cell death by suppressing leukocyte recruitment. Journal of Neurochemistry 2007, 100:1018-1031.
166. Nakazawa T., Takahashi H., Shimura M. Estrogen has a neuroprotective effect on axotomized RGCs through ERK signal transduction pathway. Brain Research 2006, 1093:141-149.
167. Nash M.S., Wood J.P., Melena J., Osborne N.N. Flupirtine ameliorates ischaemic-like death of rat retinal ganglion cells by preventing calcium influx. Brain Research 2000, 856:236-239.
168. Naskar R., Quinto K., Romann I., Schuettauf F., Zurakowski D. Phenytoin blocks retinal ganglion cell death after partial optic nerve crush. Experimental Eye Research 2002, 74:747-752.
169. Naskar R., Vorwerk C.K., Dreyer E.B. Concurrent downregulation of a glutamate transporter and receptor in glaucoma. Investigative Ophthalmology and Visual Science 2000, 41:1940-1944.
170. Neacsu A., Oprean C., Curea M., Tuchila G., Trifu M. Oftalmologia 2003, 59:70-75.
171. Neckers L. Heat shock protein 90: the cancer chaperone. Journal of Bioscience 2007, 32:517-530.
172. Negishi H., Xu J.W., Ikeda K., Njelekela M., Nara Y., Yamori Y. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. Journal of Nutrition 2004, 134:38-42.
173. Neufeld A.H. Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma. Brain Research Bulletin 2004, 62:455-459.
174. Neufeld A.H., Liu B. Glaucomatous optic neuropathy: when glia misbehave. Neuroscientist 2003, 9:485-495.
175. Neufeld A.H., Sawada A., Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:9944-9948.
176. Nickells R.W. Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Survey of Ophthalmology 1999, 43(Suppl. 1):S151-161.
177. Nucci C., Gasperi V., Tartaglione R., Cerulli A., Terrinoni A., Bari M., De Simone C., Agro A.F., Morrone L.A., Corasaniti M.T., et al. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Investigative Ophthalmology and Visual Science 2007, 48:2997-3004.
178. Nucci C., Tartaglione R., Cerulli A., Mancino R., Spano A., Cavaliere F., Rombola L., Bagetta G., Corasaniti M.T., Morrone L.A. Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. International Review of Neurobiology 2007, 82:397-406.
179. Ogueta S.B., Schwartz S.D., Yamashita C.K., Farber D.B. Estrogen receptor in the human eye: influence of gender and age on gene expression. Investigative Ophthalmology and Visual Science 1999, 40:1906-1911.
180. Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969, 164:719-721.
181. Opere C.A., Zheng W.D., Zhao M., Lee J.S., Kulkarni K.H., Ohia S.E. Inhibition of potassium- and ischemia-evoked [3H] d-aspartate release from isolated bovine retina by cannabinoids. Current Eye Research 2006, 31:645-653.
182. Osborne N.N. Pathogenesis of ganglion " cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria. Progress in Brain Research 2008, 173:339-352.
183. Osborne N.N., Ugarte M., Chao M., Chidlow G., Bae J.H., Wood J.P., Nash M.S. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Survey of Ophthalmology 1999, 43(Suppl. 1):S102-128.
184. Osborne N.N., Wood J.P., Cupido A., Melena J., Chidlow G. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity. Investigative Ophthalmology and Visual Science 2002, 43:1456-1464.
185. Otori Y., Wei J.Y., Barnstable C.J. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Investigative Ophthalmology and Visual Science 1998, 39:972-981.
186. Pang I.H., Wexler E.M., Nawy S., DeSantis L., Kapin M.A. Protection by eliprodil against excitotoxicity in cultured rat retinal ganglion cells. Investigative Ophthalmology and Visual Science 1999, 40:1170-1176.
187. Papucci L., Schiavone N., Witort E., Donnini M., Lapucci A., Tempestini A., Formigli L., Zecchi-Orlandini S., Orlandini G., Carella G., et al. Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J Biol Chem 2003, 278:28220-28228.
188. Pastorino J.G., Simbula G., Yamamoto K., Glascott P.A., Rothman R.J., Farber J.L. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. Journal of Biological Chemistry 1996, 271:29792-29798.
189. Pease M.E., Zack D.J., Berlinicke C., Bloom K., Cone F., Wang Y., Klein R.L., Hauswirth W.W., Quigley H.A. Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Investigative Ophthalmology and Visual Science 2009, 50:2194-2200.
190. Pellegrini J.W., Lipton S.A. Delayed administration of memantine prevents N-methyl-D-aspartate receptor-mediated neurotoxicity. Annals of Neurology 1993, 33:403-407.
191. Pepys M.B. Amyloidosis. Annual Review of Medicine 2006, 57:223-241.
192. Qu J., Wang D., Grosskreutz C.L. Mechanisms of retinal ganglion cell injury and defense in glaucoma. Experimental Eye Research 2010.
193. Quaranta L., Bettelli S., Uva M.G., Semeraro F., Turano R., Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 2003, 110:359-362. discussion 362-354.
194. Quigley H.A. Glaucoma: macrocosm to microcosm the Friedenwald lecture. Investigative Ophthalmology and Visual Science 2005, 46:2662-2670.
195. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 2006, 90:262-267.
196. Quigley H.A., Nickells R.W., Kerrigan L.A., Pease M.E., Thibault D.J., Zack D.J. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Investigative Ophthalmology and Visual Science 1995, 36:774-786.
197. Ray K., Mukhopadhyay A., Acharya M. Recent advances in molecular genetics of glaucoma. Molecular and Cellular Biochemistry 2003, 253:223-231.
198. Razmara A., Duckles S.P., Krause D.N., Procaccio V. Estrogen suppresses brain mitochondrial oxidative stress in female and male rats. Brain Research 2007, 1176:71-81.
199. Reisberg B., Doody R., Stoffler A., Schmitt F., Ferris S., Mobius H.J. Memantine in moderate-to-severe Alzheimer's disease. New England Journal of Medcine 2003, 348:1333-1341.
200. Rhone M., Basu A. Phytochemicals and age-related eye diseases. Nutrition Reviews 2008, 66:465-472.
201. Rodriguez-Tebar A., Jeffrey P.L., Thoenen H., Barde Y.A. The survival of chick retinal ganglion cells in response to brain-derived neurotrophic factor depends on their embryonic age. Developmental Biology 1989, 136:296-303.
202. Rosenthal A., Goeddel D.V., Nguyen T., Lewis M., Shih A., Laramee G.R., Nikolics K., Winslow J.W. Primary structure and biological activity of a novel human neurotrophic factor. Neuron 1990, 4:767-773.
203. Rudzinski M., Wong T.P., Saragovi H.U. Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertension. Journal of Neurobiology 2004, 58:341-354.
204. Russelakis-Carneiro M., Silveira L.C., Perry V.H. Factors affecting the survival of cat retinal ganglion cells after optic nerve injury. Journal of Neurocytology 1996, 25:393-402.
205. Russo R., Cavaliere F., Berliocchi L., Nucci C., Gliozzi M., Mazzei C., Tassorelli C., Corasaniti M.T., Rotiroti D., Bagetta G., Morrone L.A. Modulation of pro-survival and death-associated pathways under retinal ischemia/reperfusion: effects of NMDA receptor blockade. Journal of Neurochemistry 2008, 107:1347-1357.
206. Salt T.E., Cordeiro M.F. Glutamate excitotoxicity in glaucoma: throwing the baby out with the bathwater?. Eye (London, England) 2006, 20:730-731. author reply 731-732.
207. Samuelsson G. Drugs of Natural Origin 1999, Swedish Pharmaceutical Society, Stokholm. fourth ed.
208. 2+ with exposure to hydrostatic pressure. Investigative Ophthalmology and Visual Science 2009, 50:717-728.
209. Sattler M.B., Merkler D., Maier K., Stadelmann C., Ehrenreich H., Bahr M., Diem R. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death and Differentiation 2004, 11(Suppl. 2):S181-192.
210. Schnebelen C., Pasquis B., Salinas-Navarro M., Joffre C., Creuzot-Garcher C.P., Vidal-Sanz M., Bron A.M., Bretillon L., Acar N. A dietary combination of omega-3 and omega-6 polyunsaturated fatty acids is more efficient than single supplementations in the prevention of retinal damage induced by elevation of intraocular pressure in rats. Graefe's Archive of Clinical and Experimental Ophthalmology 2009.
211. Schori H., Kipnis J., Yoles E., WoldeMussie E., Ruiz G., Wheeler L.A., Schwartz M. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:3398-3403.
212. Schuettauf F., Naskar R., Vorwerk C.K., Zurakowski D., Dreyer E.B. Ganglion cell loss after optic nerve crush mediated through AMPA-kainate and NMDA receptors. Investigative Ophthalmology and Visual Science 2000, 41:4313-4316.
213. Schuettauf F., Zurakowski D., Quinto K., Varde M.A., Besch D., Laties A., Anderson R., Wen R. Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells. Graefe's Archive of Clinical and Experimental Ophthalmology 2005, 243:1036-1042.
214. Schwartz M. Physiological approaches to neuroprotection. boosting of protective autoimmunity. Survey of Ophthalmology 2001, 45(Suppl. 3):S256-S260. discussion S273-S256.
215. Senaldi G., Varnum B.C., Sarmiento U., Starnes C., Lile J., Scully S., Guo J., Elliott G., McNinch J., Shaklee C.L., et al. Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:11458-11463.
216. Shimazawa M., Inokuchi Y., Okuno T., Nakajima Y., Sakaguchi G., Kato A., Oku H., Sugiyama T., Kudo T., Ikeda T., et al. Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling. Journal of Neurochemistry 2008, 107:279-290.
217. Shimazawa M., Nakajima Y., Mashima Y., Hara H. Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells. Brain Research 2009, 1251:269-275.
218. Simpkins J.W., Wen Y., Perez E., Yang S., Wang X. Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology. Annals of New York Academy of Sciences 2005, 1052:233-242.
219. Singer C.A., Rogers K.L., Strickland T.M., Dorsa D.M. Estrogen protects primary cortical neurons from glutamate toxicity. Neuroscience Letters 1996, 212:13-16.
220. Siu A.W., Ortiz G.G., Benitez-King G., To C.H., Reiter R.J. Effects of melatonin on the nitric oxide treated retina. British Journal of Ophthalmology 2004, 88:1078-1081.
221. Siu A.W., To C.H. Nitric oxide and hydroxyl radical-induced retinal lipid peroxidation in vitro. Clinical and Experimental Optometry 2002, 85:378-382.
222. Skradski S., White H.S. Topiramate blocks kainate-evoked cobalt influx into cultured neurons. Epilepsia 2000, 41(Suppl. 1):S45-47.
223. Solberg Y., Rosner M., Turetz J., Belkin M. MK-801 has neuroprotective and antiproliferative effects in retinal laser injury. Investigative Ophthalmology and Visual Science 1997, 38:1380-1389.
224. Sommer A. Intraocular pressure and glaucoma. American Journal of Ophthalmology 1989, 107:186-188.
225. Soti C., Nagy E., Giricz Z., Vigh L., Csermely P., Ferdinandy P. Heat shock proteins as emerging therapeutic targets. British Journal of Pharmacology 2005, 146:769-780.
226. Sribnick E.A., Ray S.K., Nowak M.W., Li L., Banik N.L. 17beta-estradiol attenuates glutamate-induced apoptosis and preserves electrophysiologic function in primary cortical neurons. Journal of Neuroscience and Research 2004, 76:688-696.
227. Sugden D., Pickering H., Teh M.T., Garratt P.J. Melatonin receptor pharmacology: toward subtype specificity. Biology of the Cell 1997, 89:531-537.
228. Sun F.Y., Lin X., Mao L.Z., Ge W.H., Zhang L.M., Huang Y.L., Gu J. Neuroprotection by melatonin against ischemic neuronal injury associated with modulation of DNA damage and repair in the rat following a transient cerebral ischemia. Journal of Pineal Research 2002, 33:48-56.
229. Tajes Orduna M., Pelegri Gabalda C., Vilaplana Hortensi J., Pallas Lliberia M., Camins Espuny A. An evaluation of the neuroprotective effects of melatonin in an in vitro experimental model of age-induced neuronal apoptosis. Journal of Pineal Research 2009, 46:262-267.
230. Tamura Y., Sato Y., Yokota T., Akaike A., Sasa M., Takaori S. Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory sites of N-methyl-d-aspartate receptors in cultured cortical neurons. Journal of Pharmacology and Experimental Therapeutics 1993, 265:1017-1025.
231. Tang Q., Hu Y., Cao Y. Neuroprotective effect of melatonin on retinal ganglion cells in rats. Journal of Huazhong University of Science and Technology [Medicinal Science] 2006, 26:235-237. 253.
232. Tatton W.G., Chalmers-Redman R.M., Sud A., Podos S.M., Mittag T.W. Maintaining mitochondrial membrane impermeability. An opportunity for new therapy in glaucoma?. Survey of Ophthalmology 2001, 45(Suppl. 3):S277-S283. discussion S295-S276.
233. Teiten M.H., Reuter S., Schmucker S., Dicato M., Diederich M. Induction of heat shock response by curcumin in human leukemia cells. Cancer Letters 2009, 279:145-154.
234. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Progress in Retinal and Eye Research 2006, 25:490-513.
235. Tezel G., Chauhan B.C., LeBlanc R.P., Wax M.B. Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma. Investigative Ophthalmology and Visual Science 2003, 44:3025-3033.
236. Tezel G., Hernandez R., Wax M.B. Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Archives of Ophthalmology 2000, 118:511-518.
237. Tezel G., Li L.Y., Patil R.V., Wax M.B. TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Investigative Ophthalmology and Visual Science 2001, 42:1787-1794.
238. Tezel G., Seigel G.M., Wax M.B. Autoantibodies to small heat shock proteins in glaucoma. Investigative Ophthalmology and Visual Science 1998, 39:2277-2287.
239. Tezel G., Yang X. Caspase-independent component of retinal ganglion cell death, in vitro. Investigative Ophthalmology and Visual Science 2004, 45:4049-4059.
240. Tezel G., Yang X., Luo C., Cai J., Kain A.D., Powell D.W., Kuehn M.H., Pierce W.M. Hemoglobin expression and regulation in glaucoma: insights into retinal ganglion cell oxygenation. Investigative Ophthalmology and Visual Science 2009, 51:907-919.
241. Tezel G., Yang X., Luo C., Peng Y., Sun S.L., Sun D. Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Investigative Ophthalmology and Visual Science 2007, 48:705-714.
242. Tezel G., Yang X., Yang J., Wax M.B. Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice. Brain Research 2004, 996:202-212.
243. Thiagarajan G., Chandani S., Harinarayana Rao S., Samuni A.M., Chandrasekaran K., Balasubramanian D. Molecular and cellular assessment of ginkgo biloba extract as a possible ophthalmic drug. Exp Eye Res 2002, 75:421-430.
244. Thomas S.C., Ryan M.A., Shanley T.P., Wong H.R. Induction of the stress response with prostaglandin A1 increases I-kappaBalpha gene expression. FASEB Journal 1998, 12:1371-1378.
245. Tsuda K. Neuroprotective effects of MK-801 and catecholamine release in the central nervous system. Stroke 2004, 35:e96.
246. Vallazza-Deschamps G., Fuchs C., Cia D., Tessier L.H., Sahel J.A., Dreyfus H., Picaud S. Diltiazem-induced neuroprotection in glutamate excitotoxicity and ischemic insult of retinal neurons. Documenta Ophthalmologica 2005, 110:25-35.
247. Verwey N.A., Schuitemaker A., van der Flier W.M., Mulder S.D., Mulder C., Hack C.E., Scheltens P., Blankenstein M.A., Veerhuis R. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2008, 26:522-527.
248. Villemagne V.L., Pike K.E., Darby D., Maruff P., Savage G., Ng S., Ackermann U., Cowie T.F., Currie J., Chan S.G., et al. Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia 2008, 46:1688-1697.
249. Wajant H., Scheurich P. Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. Interantion Journal of Biochemistry and Cell Biology 2001, 33:19-32.
250. Wang W.P., Iyo A.H., Miguel-Hidalgo J., Regunathan S., Zhu M.Y. Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain Research 2006, 1084:210-216.
251. Ward M.S., Khoobehi A., Lavik E.B., Langer R., Young M.J. Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres. Journal of Pharmaceutical Sciences 2007, 96:558-568.
252. Wax M., Patil R. A rationale for gene targeting in glaucoma therapy. Journal of Ocular Pharmacology 1994, 10:403-410.
253. Weber A.J., Chen H., Hubbard W.C., Kaufman P.L. Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. Investigative Ophthalmology and Visual Science 2000, 41:1370-1379.
254. Wheeler L.A., Lai R., Woldemussie E. From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury. European Journal of Ophthalmology 1999, 9(Suppl. 1):S17-21.
255. Wiechmann A.F., Campbell L.D., Defoe D.M. Melatonin receptor RNA expression in Xenopus retina. Brain Research: Molecular Brain Research 1999, 63:297-303.
256. Wiechmann A.F., Wirsig-Wiechmann C.R. Melatonin receptor distribution in the brain and retina of a lizard, Anolis carolinensis. Brain Behavior and Evolution 1994, 43:26-33.
257. WoldeMussie E., Ruiz G., Wijono M., Wheeler L.A. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Investigative Ophthalmology and Visual Science 2001, 42:2849-2855.
258. WoldeMussie E., Yoles E., Schwartz M., Ruiz G., Wheeler L.A. Neuroprotective effect of memantine in different retinal injury models in rats. Journal of Glaucoma 2002, 11:474-480.
259. Yamamoto R., Yoneda S., Hara H. Neuroprotective effects of beta-secretase inhibitors against rat retinal ganglion cell death. Neuroscience Letters 2004, 370:61-64.
260. Yancheva S., Ihl R., Nikolova G., Panayotov P., Schlaefke S., Hoerr R. Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial. Aging and Mental Health 2009, 13:183-190.
261. Yang S.W., Lee B.R., Koh J.W. Protective effects of epigallocatechin gallate after UV irradiation in cultured human retinal pigment epithelial cells. Korean Journal of Ophthalmology 2007, 21:232-237.
262. Yoles E., Hauben E., Palgi O., Agranov E., Gothilf A., Cohen A., Kuchroo V., Cohen I.R., Weiner H., Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. Journal of Neuroscience 2001, 21:3740-3748.
263. Yoneda S., Hara H., Hirata A., Fukushima M., Inomata Y., Tanihara H. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Japan Journal of Ophthalmology 2005, 49:106-108.
264. Yoneda S., Tanaka E., Goto W., Ota T., Hara H. Topiramate reduces excitotoxic and ischemic injury in the rat retina. Brain Research 2003, 967:257-266.
265. Yu X., Tang Y., Li F., Frank M.B., Huang H., Dozmorov I., Zhu Y., Centola M., Cao W. Protection against hydrogen peroxide-induced cell death in cultured human retinal pigment epithelial cells by 17beta-estradiol: a differential gene expression profile. Mechanism of Ageing and Development 2005, 126:1135-1145.
266. Yuan L., Neufeld A.H. Activated microglia in the human glaucomatous optic nerve head. Journal of Neuroscience and Research 2001, 64:523-532.
267. Yucel Y.H., Gupta N., Zhang Q., Mizisin A.P., Kalichman M.W., Weinreb R.N. Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Archives of Ophthalmology 2006, 124:217-225.
268. Zhang B., Rusciano D., Osborne N.N. Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro. Brain Research 2008, 1198:141-152.
269. Zhang B., Safa R., Rusciano D., Osborne N.N. Epigallocatechin gallate, an active ingredient from green tea, attenuates damaging influences to the retina caused by ischemia/reperfusion. Brain Research 2007, 1159:40-53.
270. Zhang L., Rubinow D.R., Xaing G., Li B.S., Chang Y.H., Maric D., Barker J.L., Ma W. Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport 2001, 12:1919-1923.
271. Zhou X., Li F., Ge J., Sarkisian S.R., Tomita H., Zaharia A., Chodosh J., Cao W. Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma. Development in Neurobiology 2007, 67:603-616.